UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.727

Sortiert nach

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes

Biochimica et biophysica acta, 2016-12, Vol.1858 (12), p.3131-3140

2016

Volltextzugriff (PDF)

Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism

Biochimica et biophysica acta, 2015-02, Vol.1848 (2), p.502-509

2015

Volltextzugriff (PDF)

Biologic Activity of Carotenoids Related to Distinct Membrane Physicochemical Interactions

The American journal of cardiology, 2008-05, Vol.101 (10), p.S20-S29

2008

Volltextzugriff (PDF)

Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis

Biochimica et biophysica acta, 2007, Vol.1768 (1), p.167-174

2007

Volltextzugriff (PDF)

Lipid Peroxidation Induces Cholesterol Domain Formation in Model Membranes

The Journal of biological chemistry, 2005-11, Vol.280 (47), p.39380-39387

2005

Volltextzugriff (PDF)

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

Circulation (New York, N.Y.), 2005-12, Vol.112 (24), p.3795-3801

2005

Volltextzugriff (PDF)

Intermolecular Differences of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Contribute to Distinct Pharmacologic and Pleiotropic Actions

The American journal of cardiology, 2005-09, Vol.96 (5), p.11-23

2005

Volltextzugriff (PDF)

Effect of Enhanced Glycemic Control with Saxagliptin on Endothelial Nitric Oxide Release and CD40 Levels in Obese Rats

Journal of Atherosclerosis and Thrombosis, 2011, Vol.18(9), pp.774-783

2011

Volltextzugriff (PDF)

Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs

Atherosclerosis, 2004-12, Vol.177 (2), p.235-243

2004

Volltextzugriff (PDF)

Regulation of the Gating of BKCa Channel by Lipid Bilayer Thickness

The Journal of biological chemistry, 2007-03, Vol.282 (10), p.7276-7286

2007

Volltextzugriff (PDF)

Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism

The Journal of biological chemistry, 2006-04, Vol.281 (14), p.9337-9345

2006

Volltextzugriff (PDF)

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin

Biomedicine & pharmacotherapy, 2018-07, Vol.103, p.1231-1237

2018

Volltextzugriff (PDF)

Atorvastatin Active Metabolite Inhibits Oxidative Modification of Small Dense Low-Density Lipoprotein

Journal of cardiovascular pharmacology, 2013-08, Vol.62 (2), p.160-166

2013

Volltextzugriff (PDF)

Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model

Thrombosis research, 2010-10, Vol.126 (4), p.299-305

2010

Volltextzugriff (PDF)

Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents

Journal of cardiovascular pharmacology, 2016-07, Vol.68 (1), p.33-40

2016

Volltextzugriff (PDF)

Rofecoxib Increases Susceptibility of Human LDL and Membrane Lipids to Oxidative Damage: A Mechanism of Cardiotoxicity

Journal of cardiovascular pharmacology, 2006-05, Vol.47 Suppl 1 (Supplement 1), p.S7-S14

2006

Volltextzugriff (PDF)

Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiology

BBA - Biomembranes, 2003-03, Vol.1610 (2), p.198-207

2003

Volltextzugriff (PDF)

Synergistic Effect of Amlodipine and Atorvastatin in Reversing LDL-Induced Endothelial Dysfunction

Pharmaceutical research, 2008-08, Vol.25 (8), p.1798-1806

2008

Volltextzugriff (PDF)

Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats

Journal of cardiovascular pharmacology, 2012-11, Vol.60 (5), p.467-473

2012

Volltextzugriff (PDF)

The nonlinear effect of alkyl chain length in the membrane interactions of phenolipids: Evidence by X‐ray diffraction analysis

European journal of lipid science and technology, 2017-08, Vol.119 (8), p.n/a

2017

Volltextzugriff (PDF)

Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress

Circulation (New York, N.Y.), 2004-06, Vol.109 (21 Suppl 1), p.II34-II41

2004

Volltextzugriff (PDF)

ATORVASTATIN ACTIVE METABOLITE INHIBITS OXIDATION OF APOB-CONTAINING LIPOPROTEIN PARTICLES OF DIFFERENT SIZES MEASURED IN VITRO UNDER HYPERGLYCEMIC CONDITIONS

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.2020-2020

2017

Volltextzugriff (PDF)

Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: A longitudinal analysis of the PREVENT Study

Journal of the American College of Cardiology, 2004-11, Vol.44 (10), p.1996-2002

2004

Volltextzugriff (PDF)

Characterization of cholesterol crystalline domains in model and biological membranes using X-ray diffraction

Advances in experimental medicine and biology, 2015-01, Vol.842, p.231

2015

Volltextzugriff (PDF)

Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants

British journal of clinical pharmacology, 2012-07, Vol.74 (1), p.141-146

2012

Volltextzugriff (PDF)

1 – 25 von 1.727

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.488)
Mit Volltextzugriff
(1.489)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.142)
Life Sciences & Biomedicine
(932)
Humans
(755)
Male
(394)
Female
(387)
Middle Aged
(254)
Biological And Medical Sciences
(230)
Adult
(209)
Medical Sciences
(197)
Aged
(193)
Animals
(154)
Physical Sciences
(132)
Risk Factors
(116)
Surgery
(116)
Cardiovascular System & Cardiology
(102)
Treatment Outcome
(94)
Science & Technology - Other Topics
(92)
Medicin Och Hälsovetenskap
(88)
Neurosciences & Neurology
(86)
Adolescent
(84)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes

Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism

Biologic Activity of Carotenoids Related to Distinct Membrane Physicochemical Interactions

Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis

Lipid Peroxidation Induces Cholesterol Domain Formation in Model Membranes

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

Intermolecular Differences of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Contribute to Distinct Pharmacologic and Pleiotropic Actions

Effect of Enhanced Glycemic Control with Saxagliptin on Endothelial Nitric Oxide Release and CD40 Levels in Obese Rats

Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs

Regulation of the Gating of BKCa Channel by Lipid Bilayer Thickness

Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin

Atorvastatin Active Metabolite Inhibits Oxidative Modification of Small Dense Low-Density Lipoprotein

Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model

Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents

Rofecoxib Increases Susceptibility of Human LDL and Membrane Lipids to Oxidative Damage: A Mechanism of Cardiotoxicity

Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiology

Synergistic Effect of Amlodipine and Atorvastatin in Reversing LDL-Induced Endothelial Dysfunction

Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats

The nonlinear effect of alkyl chain length in the membrane interactions of phenolipids: Evidence by X‐ray diffraction analysis

Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress

ATORVASTATIN ACTIVE METABOLITE INHIBITS OXIDATION OF APOB-CONTAINING LIPOPROTEIN PARTICLES OF DIFFERENT SIZES MEASURED IN VITRO UNDER HYPERGLYCEMIC CONDITIONS

Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: A longitudinal analysis of the PREVENT Study

Characterization of cholesterol crystalline domains in model and biological membranes using X-ray diffraction

Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants

Suchergebnisse filtern